Geron
GERN
$4.08
Share price
3.82%
Change (1 day)
59.38%
Change (1 year)
Categories
P/S ratio for Geron (GERN)
P/S ratio as of May 2024 (TTM): > 1000
According to Geron's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9764.87. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for Geron from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | 212.34% |
| 2022 | > 1000 | 448.99% |
| 2021 | 282 | -85.55% |
| 2020 | > 1000 | 230.29% |
| 2019 | 591 | 237.86% |
| 2018 | 175 | -35.03% |
| 2017 | 269 | 403.4% |
| 2016 | 53.5 | 153.02% |
| 2015 | 21.1 | -95.24% |
| 2014 | 444 | -8.08% |
| 2013 | 483 | 612.18% |
| 2012 | 67.8 | -15.06% |
| 2011 | 79.8 | -55.29% |
| 2010 | 179 | -39.99% |
| 2009 | 298 | 125.56% |
| 2008 | 132 | 132.7% |
| 2007 | 56.7 | -69.97% |
| 2006 | 189 | -90.19% |
| 2005 | > 1000 | 343.97% |
| 2004 | 434 | 4.85% |
| 2003 | 413 | 427.29% |
| 2002 | 78.4 | 33.28% |
| 2001 | 58.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 3.00 | -99.97% | 🇺🇸 USA |
 Incyte INCY | 3.16 | -99.97% | 🇺🇸 USA |
 CTI BioPharma
CTIC | 15.8 | -99.84% | 🇺🇸 USA |
 Bio-Techne TECH | 8.68 | -99.91% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 141 | -98.56% | 🇺🇸 USA |